Xiaojun Jing

11.2k total citations · 5 hit papers
24 papers, 4.4k citations indexed

About

Xiaojun Jing is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaojun Jing has authored 24 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaojun Jing's work include Prostate Cancer Treatment and Research (8 papers), Cancer-related molecular mechanisms research (6 papers) and Ubiquitin and proteasome pathways (4 papers). Xiaojun Jing is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Cancer-related molecular mechanisms research (6 papers) and Ubiquitin and proteasome pathways (4 papers). Xiaojun Jing collaborates with scholars based in United States, China and India. Xiaojun Jing's co-authors include Xuhong Cao, Arul M. Chinnaiyan, Nallasivam Palanisamy, Christopher A. Maher, Bo Han, Qi Cao, Bharathi Laxman, Chandan Kumar‐Sinha, Irfan A. Asangani and Sooryanarayana Varambally and has published in prestigious journals such as Nature, Science and Nature Biotechnology.

In The Last Decade

Xiaojun Jing

22 papers receiving 4.3k citations

Hit Papers

Genomic Loss of microRNA-101 Leads to Overexpression of H... 2007 2026 2013 2019 2008 2011 2014 2009 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
    2008 833 citations Sooryanarayana Varambally, Qi Cao et al. Science profile →
  2. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
    2011 815 citations John R. Prensner, Matthew K. Iyer et al. Nature Biotechnology profile →
  3. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
    2014 737 citations Irfan A. Asangani, Vijaya L. Dommeti et al. Nature profile →
  4. Transcriptome sequencing to detect gene fusions in cancer
    2009 631 citations Christopher A. Maher, Chandan Kumar‐Sinha et al. Nature profile →
  5. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
    2007 610 citations Scott A. Tomlins, Bharathi Laxman et al. Nature profile →

Peers

Xiaojun Jing
Xiaoju Wang China
Robert J. Lonigro United States
John R. Prensner United States
Suk Hang Cheng Hong Kong
Jesse J. Salk United States
Yue Peng China
Brian C. Lewis United States
В. И. Кашуба Sweden
Ran Brosh Israel
Peter M. Haverty United States
Xiaoju Wang China
Xiaojun Jing
Citations per year, relative to Xiaojun Jing Xiaojun Jing (= 1×) peers Xiaoju Wang

Countries citing papers authored by Xiaojun Jing

Since Specialization
Citations

This map shows the geographic impact of Xiaojun Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Jing more than expected).

Fields of papers citing papers by Xiaojun Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Jing. The network helps show where Xiaojun Jing may publish in the future.

Co-authorship network of co-authors of Xiaojun Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojun Jing. A scholar is included among the top collaborators of Xiaojun Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojun Jing. Xiaojun Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Zhiyue, et al.. (2025). Spectrum Sensing Meets ISAC: An Spectrum Detection Scheme for ISAC Services Based on Improved Denoising Auto-Encoder and CNN. Applied Sciences. 15(6). 3381–3381. 1 indexed citations
3.
Jing, Xiaojun, et al.. (2025). The Potential Role of Neurogranin in Alzheimer’s Disease. Journal of Integrative Neuroscience. 24(3). 25368–25368. 1 indexed citations
4.
Therriault, Joseph, et al.. (2022). The associations of serum valine with mild cognitive impairment and Alzheimer’s disease. Aging Clinical and Experimental Research. 34(8). 1807–1817. 11 indexed citations
5.
Tiwari, Ritika, Swaroop Kumar Pandey, Sakshi Goel, et al.. (2021). Correction: SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression. Oncogenesis. 10(2). 16–16. 2 indexed citations
6.
Chakravarthi, Balabhadrapatruni V. S. K., Darshan S. Chandrashekar, Sumit Agarwal, et al.. (2017). miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression. Molecular Cancer Research. 16(7). 1125–1137. 51 indexed citations
7.
Wang, Xiaoju, Yuanyuan Qiao, Irfan A. Asangani, et al.. (2017). Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer. Cancer Cell. 31(4). 532–548.e7. 78 indexed citations
8.
Shukla, Sudhanshu, Xiang Zhang, Yashar S. Niknafs, et al.. (2016). Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer. Neoplasia. 18(8). 489–499. 56 indexed citations
9.
Chakravarthi, Balabhadrapatruni V. S. K., Moloy T. Goswami, Satya S. Pathi, et al.. (2016). MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer. Oncogene. 35(49). 6330–6340. 55 indexed citations
10.
Tiwari, Ritika, Swaroop Kumar Pandey, Sakshi Goel, et al.. (2015). SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression. Oncogenesis. 4(8). e162–e162. 49 indexed citations
11.
Malik, Rohit, Lalit R. Patel, John R. Prensner, et al.. (2014). The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer. Molecular Cancer Research. 12(8). 1081–1087. 112 indexed citations
12.
Asangani, Irfan A., Vijaya L. Dommeti, Xiaoju Wang, et al.. (2014). Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature. 510(7504). 278–282. 737 indexed citations breakdown →
13.
Mehra, Rohit, Chandan Kumar‐Sinha, Sunita Shankar, et al.. (2011). Characterization of Bone Metastases from Rapid Autopsies of Prostate Cancer Patients. Clinical Cancer Research. 17(12). 3924–3932. 67 indexed citations
14.
Lonigro, Robert J., Catherine S. Grasso, Dan R. Robinson, et al.. (2011). Detection of Somatic Copy Number Alterations in Cancer Using Targeted Exome Capture Sequencing. Neoplasia. 13(11). 1019–IN21. 55 indexed citations
15.
Banerjee, Rajat, Ram S. Mani, Nickole Russo, et al.. (2011). The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma. Oncogene. 30(42). 4339–4349. 90 indexed citations
16.
Prensner, John R., Matthew K. Iyer, O. Alejandro Balbin, et al.. (2011). Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nature Biotechnology. 29(8). 742–749. 815 indexed citations breakdown →
17.
Maher, Christopher A., Chandan Kumar‐Sinha, Xuhong Cao, et al.. (2009). Transcriptome sequencing to detect gene fusions in cancer. Nature. 458(7234). 97–101. 631 indexed citations breakdown →
18.
Varambally, Sooryanarayana, Qi Cao, Ram S. Mani, et al.. (2008). Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer. Science. 322(5908). 1695–1699. 833 indexed citations breakdown →
19.
Tomlins, Scott A., Bharathi Laxman, Saravana M. Dhanasekaran, et al.. (2007). Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 448(7153). 595–599. 610 indexed citations breakdown →
20.
Jing, Xiaojun, et al.. (2001). Inhibition of Adenovirus Cytotoxicity, Replication, and E2a Gene Expression by Adeno-Associated Virus. Virology. 291(1). 140–151. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoju Wang Breakdown of academic impact, for papers by Robert J. Lonigro Breakdown of academic impact, for papers by John R. Prensner Breakdown of academic impact, for papers by Suk Hang Cheng Breakdown of academic impact, for papers by Jesse J. Salk Breakdown of academic impact, for papers by Yue Peng Breakdown of academic impact, for papers by Brian C. Lewis Breakdown of academic impact, for papers by В. И. Кашуба Breakdown of academic impact, for papers by Ran Brosh Breakdown of academic impact, for papers by Peter M. Haverty
Rankless by CCL
2026